MeCP2 NID interaction with RNA: implications for Rett syndrome-relevant protein regulation.

Area of Science:

• Molecular Biology
• Neurogenetics
• Epigenetics

Background:

• Rett syndrome is a progressive neurodevelopmental disorder caused by mutations in the X-linked MECP2 gene.
• Key MeCP2 functional domains include the Methyl DNA binding Domain (MBD) and the Nuclear receptor Co-Repressor (NCoR) Interaction Domain (NID).
• The NID's role in transcriptional repression via co-repressor complex binding is established, but its potential RNA interaction is underexplored.

Purpose of the Study:

• To investigate the role of RNA interaction with the MeCP2 protein, specifically at the NID/RBD.
• To determine if RNA binding affects MeCP2's interaction with chromatin or protein partners like NCoR.
• To elucidate the functional significance of RNA-MeCP2 interactions in the context of Rett syndrome.

Main Methods:

• Utilized cell-based and in vitro molecular assays.
• Validated RNA binding of MeCP2 to a double-stranded RNA (dsRNA) probe and the long non-coding RNA NEAT1_2.
• Assessed MeCP2-chromatin interactions and MeCP2-NCoR binding in the presence and absence of RNA interaction.

Main Results:

• Confirmed RNA interaction at the MeCP2 NID/RBD with both dsRNA in vitro and NEAT1_2 in cells.
• Demonstrated that RNA binding at this domain does not disrupt MeCP2-chromatin interactions.
• Showed that RNA interaction with the MeCP2 RBD precludes its binding to NCoR within cells.

Conclusions:

• RNA interaction with the MeCP2 NID/RBD is a validated biological event.
• This RNA binding event regulates critical MeCP2 protein-protein interactions, specifically inhibiting NCoR binding.
• RNA interaction at this domain represents a novel regulatory mechanism for MeCP2 function and may be a key factor in Rett syndrome pathophysiology.